European Diabetes Technology Course

Information Coming Soon


Physician ACCME Accreditation

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of CMI Education Institute, Inc., and Diabetes Technology Society. CMI Education Institute is accredited by the ACCME to provide continuing medical education for physicians.

CMI Education Institute designates this live educational activity for a maximum of 15 AMA PRA Category 1 Credit(s) ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

International CME
International physicians are formally eligible for AMA PRA Category 1 Credit™.

Physician Assistants
AAPA accepts Category 1 credit from AOACCME, prescribed credit from AAFP, and AMA PRA Category 1 Credit™ for the PRA from organizations accredited by ACCME.

Continuing Nursing Education Accreditation
Aspen CME Services is an approved provider of continuing nursing education by the Wisconsin Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. 
 Aspen CME Services designates this activity for 15 contact hours.

California Nurses
Aspen CME Services is approved by the California Board of Registered Nursing, provider number CEP14739, for 15 contact hours.

The National Certification Board for Diabetes Educators recognizes courses sponsored by CMI Education Institute Inc. and Wisconsin Nurses Association both approved providers. This course qualifies for 15 continuing education hours.

Satisfactory Completion for Credits:
All attendees must have completed and turned in a course attendance/evaluation form prior to leaving the conference.  Each session claimed for credit must be attended in its entirety.

Disclosure of Conflicts of Interest
CMI Education Institute, Inc. and Aspen CME Services require instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by CMI Education Institute, Inc. and Aspen CME Services for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA.  CMI Education Institute, Inc, Aspen CME Services and Diabetes Technology Society do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with the activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindication, and warnings.

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in the activity should not be used by clinicians without evaluation of patient condition and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.